Commonwealth Equity Services’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,696
Closed -$307K 4183
2024
Q4
$307K Sell
2,696
-442
-14% -$50.4K ﹤0.01% 3375
2024
Q3
$373K Sell
3,138
-21
-0.7% -$1.93K ﹤0.01% 3152
2024
Q2
$254K Sell
3,159
-677
-18% -$61.9K ﹤0.01% 3443
2024
Q1
$354K Sell
3,836
-7,043
-65% -$675K ﹤0.01% 3116
2023
Q4
$1.15M Buy
10,879
+260
+2% +$26.2K ﹤0.01% 2077
2023
Q3
$1.15M Sell
10,619
-766
-7% -$84.7K ﹤0.01% 1978
2023
Q2
$1.23M Sell
11,385
-255
-2% -$28.7K ﹤0.01% 1948
2023
Q1
$1.45K Buy
11,640
+3,203
+38% +$440K ﹤0.01% 1774
2022
Q4
$1.27M Sell
8,437
-4,816
-36% -$741K ﹤0.01% 1803
2022
Q3
$1.79M Buy
13,253
+8,684
+190% +$1.33M ﹤0.01% 1498
2022
Q2
$681K Sell
4,569
-469
-9% -$71.7K ﹤0.01% 2189
2022
Q1
$859K Sell
5,038
-1,857
-27% -$312K ﹤0.01% 2114
2021
Q4
$1.78M Sell
6,895
-1,008
-13% -$276K ﹤0.01% 1574
2021
Q3
$2.16M Sell
7,903
-139
-2% -$44.2K 0.01% 1380
2021
Q2
$1.8M Sell
8,042
-528
-6% -$99.6K ﹤0.01% 1495
2021
Q1
$935K Buy
8,570
+769
+10% +$81.7K ﹤0.01% 1844
2020
Q4
$635K Buy
7,801
+2,238
+40% +$220K ﹤0.01% 1974
2020
Q3
$385K Buy
+5,563
New +$399K ﹤0.01% 2168

Other funds holding BNTX

Commonwealth Equity Services's BNTX Position: Q1 2025 in Review

Commonwealth Equity Services sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 2,696 shares — an estimated $307K sold.

Commonwealth Equity Services first reported a position in BNTX in Q3 2020 and held it in 18 quarters. The position peaked at $2.16M in Q3 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Commonwealth Equity Services reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 2,696 BioNTech shares in Q1 2025, an estimated $307K.
  • Commonwealth Equity Services first reported a position in BioNTech in Q3 2020 and held it in 18 quarters.
  • Commonwealth Equity Services's BioNTech position peaked at $2.16M in Q3 2021.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.